No.
|
At presentation
|
Follow-up
|
---|
|
AP deficiency
|
GH (ng/mL, <2.5)
|
IGF1 (ng/mL, 74–388)
|
ACTH (pg/mL, 0–46)
|
Cortisol (μg/dL, 4–25)
|
LH (IU/L, 1.2–58.64)
|
FSH (IU/L, 1.27–113.59)
|
PRL (ng/mL, 2.74–26.72)
|
E2 (pg/mL, 20–273)
|
T (ng/dL, 0.1–7.8)
|
TSH (μIU/mL,0.38–4.34)
|
FT4 (ng/dL,0.81–1.89)
|
AP deficiency
|
---|
1
|
Panhypopituitary
|
0.2
|
25
|
15.29
|
0.81
|
0
|
0.2
|
15.84
|
10.4
|
11.2
|
0.202
|
0.56
|
Panhypopituitary
|
2
|
Not impaired
|
0.5
|
129
|
28. 6
|
13.51
|
3.12
|
4.91
|
37.1
|
44
|
0.19
|
1.54
|
1.22
|
Not impaired
|
3
|
GH, LH-FSH deficiency
|
<0.05
|
72
|
26.3
|
12.05
|
0.43
|
0.36
|
17.39
|
25
|
<0.1
|
8.485
|
1.01
|
Panhypopituitary
|
4
|
Not impaired
|
1.4
|
198
|
30.6
|
12.9
|
2.63
|
1.0
|
15.6
|
11.8
|
360.8
|
2.662
|
1.380
|
NA
|
5
|
Panhypopituitary
|
<0.05
|
44
|
7.6
|
0.74
|
0
|
0.3
|
11.7
|
10.2
|
5.2
|
2.539
|
0.60
|
Panhypopituitary
|
6
|
Not impaired
|
0.2
|
381
|
51.3
|
13.65
|
4.7
|
4.42
|
18.14
|
56
|
2.11
|
2.581
|
1.333
|
Not impaired
|
7
|
Panhypopituitary
|
0.12
|
68
|
7.6
|
0.2
|
5.2
|
1.67
|
51.22
|
0.09
|
0.73
|
0.26
|
0.77
|
Panhypopituitary
|
-
AP anterior pituitary, GH growth hormone, IGF1 insulin-like growth factor-1, ACTH adrenocorticotropic hormone, LH luteinizing hormone, FSH follicle-stimulating hormone, PRL prolactin, E2 oestradiol, T testosterone, TSH thyroid-stimulating hormone, FT4 free thyroxine